Another virus of concern

The year 2025 has dawned with a new respiratory illness- caused by human metapneumovirus (HMPV)-outbreak in China creating a scare among the people here. Coming as it does five years since the outbreak of Covid-19, which wreaked havoc in many parts of the world, there are reasons for panic. The surge in infections is still being examined as the outbreak coincides with winter, a time when cases of respiratory illnesses usually peak. As per reports, the HMPV is spreading along with multiple viruses like influenza A, Mycoplasma pneumoniae and Covid-19. Although social media is replete with posts claiming that the situation is dire in China, neither the World Health Organization (WHO) nor Centre for Disease Control and Prevention (CDC) has declared any stage of emergency so far. The human metapneumovirus (HMPV), a virus that affects the upper respiratory system, sometimes causing lower respiratory infections, was first discovered in 2001. HMPV, a highly contagious respiratory virus, spreads through droplets, direct contact, and contaminated surfaces. Vulnerable groups include young children, older adults, and those with weakened immunity. Symptoms often resemble the flu but can escalate in severe cases. As countries like India and Malaysia monitor rising cases, vigilance is essential. According to the US Centres for Disease Control and Prevention (CDC), it affects individuals across all age groups, especially those with weak immune systems or chronic respiratory conditions like asthma or chronic obstructive pulmonary disease (COPD). Infants, children under the age of five, and adults over the age of 65 are also at risk. HMPV is more common in winter and early spring and people affected by it show symptoms similar to a common cold or flu. Cough, runny or stuffy nose, fever, sore throat, wheezing or shortness of breath to name a few. In some cases, the infection can escalate to bronchitis, pneumonia or asthma exacerbations. HMPV spreads through close contact with people affected by the virus, especially through droplets from coughing or sneezing, close contact such as touching or shaking hands, contaminated surfaces, followed by touching the mouth, nose or eyes. HMPV is not a new virus and does not cause an imminent pandemic threat. However, the seasonal surges are typical as people re-expose to pathogens post Covid 19. There are no specific vaccines for HMPV. One can focus on alleviating symptoms by staying hydrated, taking proper rest and using over-the-counter (OTC) medications for pain, congestion, and fever. Experts from India’s Directorate General of Health Services (DGHS) have urged calm amid rising concerns about human metapneumovirus (HMPV). An official of the DGHS assured the public that there was no immediate cause for alarm, emphasizing the importance of preventive measures such as mask-wearing and hand hygiene to limit the spread of respiratory infections. In a proactive move, the government of India recently conducted a nationwide readiness drill to assess the country’s ability to manage any potential surge in HMPV cases. This exercise is to demonstrate a commitment to vigilance and preparedness, reflecting lessons learned from past health crises. While HMPV has gained attention worldwide, it is a familiar seasonal virus with no current vaccine. Preventing its spread relies on individual responsibility and basic hygiene practices. India’s measured approach should reassure the public while underscoring the importance of community-wide cooperation in staying ahead of potential health challenges.